Annual report [Section 13 and 15(d), not S-K Item 405]

SEGMENT INFORMATION (Tables)

v3.25.0.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
SEGMENT INFORMATION  
Schedule of segment information

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31,

​

 

2024

    

2023

    

2022

​

​

(in thousands)

Total Revenues

​

$

179,278

​

$

116,882

​

$

120,242

Less:

​

​

​

​

​

​

​

​

​

Employee related expenses

​

​

69,807

​

​

63,429

​

​

69,477

Commercial related expenses

​

​

26,996

​

​

24,310

​

​

23,846

Cost of product sales

​

​

18,647

​

​

7,110

​

​

1,749

Consultants and third-party services

​

​

15,532

​

​

17,942

​

​

22,218

Outside clinical trial related expenses

​

​

10,978

​

​

9,694

​

​

29,981

Other segment items

​

​

13,126

​

​

14,888

​

​

28,521

Interest expense, net

​

​

5,826

​

​

4,600

​

​

3,023

Provision for income taxes

​

​

881

​

​

—

​

​

—

Segment income (loss)

​

$

17,485

​

$

(25,091)

​

$

(58,573)